Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

No cure exists for alopecia areata, and treatments are personalized.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Immune cells affect hair growth and could lead to new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The microbiome may be linked to hair loss and could be a target for new treatments.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Oral Apremilast effectively treats alopecia areata in most patients.

Tofacitinib helped regrow hair in most patients with severe hair loss.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.